Program & Portfolio Strategy Intern (Graduate Level)

Lexeo Therapeutics is a New York City-based, clinical stage genetic medicine company dedicated to transforming healthcare by applying pioneering science to fundamentally change how genetically defined cardiovascular diseases are treated. Using a stepwise development approach, Lexeo is leveraging early proof-of-concept functional and biomarker data to advance a pipeline of rare cardiovascular disease programs focused on Friedreich’s ataxia (FA) cardiomyopathy and arrhythmogenic cardiomyopathy (A…